Corinne Inauen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Corinne Inauen has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Susanne Wegener
Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland
6 shared publications - Andreas Rüdiger Luft
University Hospital Zurich and University of Zurich
4 shared publications Thomas Pokorny
Department of Neurology & Stroke Center, University Hospital of Basel & University of Basel, Basel, Switzerland
4 shared publications- Urs Fischer
Department of Neurology, University Hospital Bern and University of Bern, Switzerland (U.F.).
4 shared publications - Alejandro Bustamante
Stroke Unit, Department of Neurology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona , Badalona
3 shared publications - Christoph Globas
Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
3 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (10) , 1136
Intraoperative Measurement of Internal Carotid Artery Blood Flow Using Transit-Time Flowmetry After Carotid Endarterectomy: Results from 196 Consecutive Cases
Background/Objectives: Carotid endarterectomy (CEA) is a standard surgical treatment for high-grade symptomatic and asymptomatic internal carotid artery (ICA) stenosis. The Transit Time Flowmeter (TTF) provides an easy-to-use tool to quantify intraoperative ICA blood flow in mL/min. This study aimed to (1) describe post-CEA ICA flow quantified with TTF, (2) identify predictors of post-CEA ICA flow, and (3) examine its association with contralateral steno-occlusive disease. Methods: We queried data from our prospective registry of patients who underwent a CEA between January 2019 and July 2024 and had intraoperative registered post-CEA ICA flow measurements using TTF. Preoperative ICA stenosis was graded according to the NASCET criteria. The clinical data was retrospectively collected. Results: Data from 196 CEAs in 190 patients (median age 74 [67–81]; 25% female) were included. Most patients (86%) had a symptomatic ICA stenosis. The median post-CEA ICA flow was 170 mL/min [IQR 140–242; range 40–800]. Post-CEA ICA flow was not associated with age, sex, comorbidities, symptomatic stenosis, left ventricular ejection fraction (LVEF), or ipsilateral stenosis severity but was significantly higher in patients requiring intraluminal shunt placement during CEA (p = 0.010) as well as in those with contralateral steno-occlusive disease (p < 0.001). Conclusions: TTF is a practical intraoperative tool for quantitative flow assessment during CEA. Higher post-CEA ICA flow in patients with an intraoperative shunt placement or with contralateral steno-occlusive disease may reflect a compensatory hyperperfusion, as the ipsilateral ICA serves as a key supplier when collateral pathways are incomplete.
- 21 October 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (10) , 1136
Open AccessIntraoperative Measurement of Internal Carotid Artery Blood Flow Using Transit-Time Flowmetry After Carotid Endarterectomy: Results from 196 Consecutive Cases
Background/Objectives: Carotid endarterectomy (CEA) is a standard surgical treatment for high-grade symptomatic and asymptomatic internal carotid artery (ICA) stenosis. The Transit Time Flowmeter (TTF) provides an easy-to-use tool to quantify intraoperative ICA blood flow in mL/min. This study aimed to (1) describe post-CEA ICA flow quantified with TTF, (2) identify predictors of post-CEA ICA flow, and (3) examine its association with contralateral steno-occlusive disease. Methods: We queried data from our prospective registry of patients who underwent a CEA between January 2019 and July 2024 and had intraoperative registered post-CEA ICA flow measurements using TTF. Preoperative ICA stenosis was graded according to the NASCET criteria. The clinical data was retrospectively collected. Results: Data from 196 CEAs in 190 patients (median age 74 [67–81]; 25% female) were included. Most patients (86%) had a symptomatic ICA stenosis. The median post-CEA ICA flow was 170 mL/min [IQR 140–242; range 40–800]. Post-CEA ICA flow was not associated with age, sex, comorbidities, symptomatic stenosis, left ventricular ejection fraction (LVEF), or ipsilateral stenosis severity but was significantly higher in patients requiring intraluminal shunt placement during CEA (p = 0.010) as well as in those with contralateral steno-occlusive disease (p < 0.001). Conclusions: TTF is a practical intraoperative tool for quantitative flow assessment during CEA. Higher post-CEA ICA flow in patients with an intraoperative shunt placement or with contralateral steno-occlusive disease may reflect a compensatory hyperperfusion, as the ipsilateral ICA serves as a key supplier when collateral pathways are incomplete.
- Open Access
- 25 July 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (8) , 857
Heart Rate Variability Integrated into a Longitudinal Multimodal Model to Predict Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage
Background: Delayed cerebral ischemia (DCI) is a major cause of morbidity after aneurysmal subarachnoid hemorrhage (aSAH), yet early prediction remains difficult, especially in comatose patients. Existing risk scores are largely static and do not capture dynamic pathophysiological changes. Heart rate variability (HRV), reflecting autonomic nervous system activity, may provide additional predictive information. We investigated whether integrating HRV into a longitudinal multimodal model improves DCI prediction. Methods: In this prospective cohort study, continuous ECG data were collected from patients with aSAH admitted to a tertiary neurocritical care unit between 2016 and 2024. HRV features were computed in real time from high-resolution ECG recordings and combined with demographic, clinical, laboratory, and blood gas variables. Four prediction models were evaluated: static clinical variables, laboratory/blood gas data, HRV features, and a multimodal combined model. Performance was assessed using cross-validation, anchored ROC analysis, and leave-one-out simulations. Results: Among 101 eligible patients, 35 (34.7%) developed DCI. LFNorm showed the best univariate HRV performance (ROC AUC 0.64). HRV features and laboratory/blood gas models achieved ROC AUCs of 0.60 and 0.63, respectively. The multimodal model achieved the highest overall performance (ROC AUC 0.68), with HRV features accounting for more than half of the model’s feature importance. Time-resolved analyses further demonstrated that the contribution of HRV varied across the clinical course, providing the greatest incremental value during the later phase preceding DCI. Conclusions: Integrating HRV into a multimodal prediction framework provides additional time-dependent information for DCI risk estimation in patients with aSAH.
- 25 July 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (8) , 857
Open AccessHeart Rate Variability Integrated into a Longitudinal Multimodal Model to Predict Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage
Background: Delayed cerebral ischemia (DCI) is a major cause of morbidity after aneurysmal subarachnoid hemorrhage (aSAH), yet early prediction remains difficult, especially in comatose patients. Existing risk scores are largely static and do not capture dynamic pathophysiological changes. Heart rate variability (HRV), reflecting autonomic nervous system activity, may provide additional predictive information. We investigated whether integrating HRV into a longitudinal multimodal model improves DCI prediction. Methods: In this prospective cohort study, continuous ECG data were collected from patients with aSAH admitted to a tertiary neurocritical care unit between 2016 and 2024. HRV features were computed in real time from high-resolution ECG recordings and combined with demographic, clinical, laboratory, and blood gas variables. Four prediction models were evaluated: static clinical variables, laboratory/blood gas data, HRV features, and a multimodal combined model. Performance was assessed using cross-validation, anchored ROC analysis, and leave-one-out simulations. Results: Among 101 eligible patients, 35 (34.7%) developed DCI. LFNorm showed the best univariate HRV performance (ROC AUC 0.64). HRV features and laboratory/blood gas models achieved ROC AUCs of 0.60 and 0.63, respectively. The multimodal model achieved the highest overall performance (ROC AUC 0.68), with HRV features accounting for more than half of the model’s feature importance. Time-resolved analyses further demonstrated that the contribution of HRV varied across the clinical course, providing the greatest incremental value during the later phase preceding DCI. Conclusions: Integrating HRV into a multimodal prediction framework provides additional time-dependent information for DCI risk estimation in patients with aSAH.
- Open Access
Human Intuition vs. Computational Precision: Neurologists, Feature-based Models, and Deep Learning for Stroke Prognosis
Background: Prognostication in large vessel occlusion (LVO) stroke remains challenging. Although several prognostic models exist, their comparison to clinician performance, human-model interaction, and specific sources of human bias remain poorly understood. Methods: Using pre-treatment clinical and CT data from the MR CLEAN trial (n=500), six neurologists predicted three-month modified Rankin Scale (mRS) scores for 40 patients, both unaided and assisted by a validated feature-based model (MR PREDICTS). Human performance was benchmarked against MR PREDICTS and a multimodal, interpretable deep learning (DL) approach using raw imaging data. We explicitly assessed neurologists’ ability to estimate model-required imaging features and identified systematic human biases. Models were additionally validated in a larger MR CLEAN trial cohort (n=404). Results: For predicting the full mRS distribution, standalone models achieved good ordinal agreement (MR PREDICTS quadratic weighted kappa (QWK) 0.51 [0.24 to 0.70]; DL model 0.49 [0.25 to 0.67]), significantly outperforming unaided neurologists (QWK 0.27 [0.10, 0.42]). Neurologists showed systematic overoptimism, predicting lower mRS scores than observed. Furthermore, there was poor accuracy in extracting imaging features. Raters’ ASPECTS predictions deviated by 3.4 points from the confirmed scores, and collateral score accuracy was 44.6%. However, for predicting binary mRS (0-2 vs. 3-6), accuracy was comparable between unaided neurologists (64.17% [55.42% to 72.92%]) and models (MR PREDICTS 67.50% [52.50% to 82.50%]; DL model 63.16% [47.37% to 78.95%]). Model-assistance modestly improved and harmonized neurologists’ predictions (QWK 0.41 [0.22 to 0.55]; binary accuracy 68.75% [58.33% to 78.34%]. Model performance remained robust in the larger cohort. Conclusions: Multimodal prognostic models outperform clinicians in predicting the full range of mRS outcomes, while human error in imaging assessment and systematic optimism bias are primary drivers of prognostic inaccuracy. End-to-end DL models eliminate human-input variability and hold strong potential as an automated second opinion to support prognostication and decision-making in acute LVO stroke.
Open AccessHuman Intuition vs. Computational Precision: Neurologists, Feature-based Models, and Deep Learning for Stroke Prognosis
Background: Prognostication in large vessel occlusion (LVO) stroke remains challenging. Although several prognostic models exist, their comparison to clinician performance, human-model interaction, and specific sources of human bias remain poorly understood. Methods: Using pre-treatment clinical and CT data from the MR CLEAN trial (n=500), six neurologists predicted three-month modified Rankin Scale (mRS) scores for 40 patients, both unaided and assisted by a validated feature-based model (MR PREDICTS). Human performance was benchmarked against MR PREDICTS and a multimodal, interpretable deep learning (DL) approach using raw imaging data. We explicitly assessed neurologists’ ability to estimate model-required imaging features and identified systematic human biases. Models were additionally validated in a larger MR CLEAN trial cohort (n=404). Results: For predicting the full mRS distribution, standalone models achieved good ordinal agreement (MR PREDICTS quadratic weighted kappa (QWK) 0.51 [0.24 to 0.70]; DL model 0.49 [0.25 to 0.67]), significantly outperforming unaided neurologists (QWK 0.27 [0.10, 0.42]). Neurologists showed systematic overoptimism, predicting lower mRS scores than observed. Furthermore, there was poor accuracy in extracting imaging features. Raters’ ASPECTS predictions deviated by 3.4 points from the confirmed scores, and collateral score accuracy was 44.6%. However, for predicting binary mRS (0-2 vs. 3-6), accuracy was comparable between unaided neurologists (64.17% [55.42% to 72.92%]) and models (MR PREDICTS 67.50% [52.50% to 82.50%]; DL model 63.16% [47.37% to 78.95%]). Model-assistance modestly improved and harmonized neurologists’ predictions (QWK 0.41 [0.22 to 0.55]; binary accuracy 68.75% [58.33% to 78.34%]. Model performance remained robust in the larger cohort. Conclusions: Multimodal prognostic models outperform clinicians in predicting the full range of mRS outcomes, while human error in imaging assessment and systematic optimism bias are primary drivers of prognostic inaccuracy. End-to-end DL models eliminate human-input variability and hold strong potential as an automated second opinion to support prognostication and decision-making in acute LVO stroke.
- Open Access
- 20 May 2026
- Published by Springer Nature in Neuroradiology
- Vol. 68 (8) , 2415-2426
Duplex ultrasound in severe carotid stenosis: diagnostic performance for differentiating near-occlusion subtypes from conventional high-grade stenosis
Carotid near-occlusion (CNO) is a subtype of severe carotid stenosis characterized by partial or complete distal internal carotid artery (ICA) collapse. Its diagnosis currently relies on angiographic imaging, and no validated duplex ultrasound (DUS) criteria exist. We aimed to assess the utility of DUS in distinguishing conventional high-grade stenosis (HGS), CNO without, and CNO with full collapse. We retrospectively included patients with > 80% NASCET stenosis on DUS (2012-2021) who underwent CTA, MRA, or DSA within 3 months. DUS parameters were compared across groups defined by angiographic classification using uni- and multivariable analyses. Among 78 patients, 21 had HGS, 34 CNO without, and 23 CNO with full collapse. DUS agreed with angiographic classification in 54%, with CNO without full collapse often misclassified as HGS (85%). Velocity-based DUS metrics could not reliably distinguish CNO without full collapse from HGS. However, CNO with full collapse was distinguishable based on stenotic and distal peak-systolic and end-diastolic velocities and derived ratios (AUCs 0.70-0.76). Diameter-based metrics distinguished HGS from both CNO types: distal ICA < 3.15 mm (AUC 0.79) and ICA/ECA ratio < 0.98 (AUC 0.78). Multivariable models increased discriminatory performance (AUC 0.82). Velocity-based DUS metrics cannot reliably distinguish HGS from CNO without full collapse, representing a key clinical challenge. Although DUS-derived metrics were associated with angiographically defined CNO with full collapse, overall diagnostic gain was modest and additional imaging will often remain necessary. Nevertheless, DUS remains useful for follow-up, as hemodynamic changes may indicate evolving distal collapse.
- 20 May 2026
- Published by Springer Nature in Neuroradiology
- Vol. 68 (8) , 2415-2426
Open AccessDuplex ultrasound in severe carotid stenosis: diagnostic performance for differentiating near-occlusion subtypes from conventional high-grade stenosis
Carotid near-occlusion (CNO) is a subtype of severe carotid stenosis characterized by partial or complete distal internal carotid artery (ICA) collapse. Its diagnosis currently relies on angiographic imaging, and no validated duplex ultrasound (DUS) criteria exist. We aimed to assess the utility of DUS in distinguishing conventional high-grade stenosis (HGS), CNO without, and CNO with full collapse. We retrospectively included patients with > 80% NASCET stenosis on DUS (2012-2021) who underwent CTA, MRA, or DSA within 3 months. DUS parameters were compared across groups defined by angiographic classification using uni- and multivariable analyses. Among 78 patients, 21 had HGS, 34 CNO without, and 23 CNO with full collapse. DUS agreed with angiographic classification in 54%, with CNO without full collapse often misclassified as HGS (85%). Velocity-based DUS metrics could not reliably distinguish CNO without full collapse from HGS. However, CNO with full collapse was distinguishable based on stenotic and distal peak-systolic and end-diastolic velocities and derived ratios (AUCs 0.70-0.76). Diameter-based metrics distinguished HGS from both CNO types: distal ICA < 3.15 mm (AUC 0.79) and ICA/ECA ratio < 0.98 (AUC 0.78). Multivariable models increased discriminatory performance (AUC 0.82). Velocity-based DUS metrics cannot reliably distinguish HGS from CNO without full collapse, representing a key clinical challenge. Although DUS-derived metrics were associated with angiographically defined CNO with full collapse, overall diagnostic gain was modest and additional imaging will often remain necessary. Nevertheless, DUS remains useful for follow-up, as hemodynamic changes may indicate evolving distal collapse.
- Open Access
- 31 January 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (2) , 171
Serial Intracranial Flow Rate Measurements Using Quantitative Magnetic Resonance Angiography Following Large-Vessel Occlusion Stroke
Background/Objectives: Haemodynamic changes following ischaemic large-vessel occlusion (LVO) stroke might affect clinical outcome, including after endovascular recanalization. Using non-invasive quantitative MRA (qMRA), we report for the first time serial intracranial flow rate measurements following LVO and investigate flow rate changes, collateral pathway development, and their possible clinical significance. Methods: We report data from the prospective IMPreST study (Interplay of Microcirculation and Plasticity after Ischemic Stroke, registered at clinicaltrials.gov, no. NCT04035746). Patients with first-ever unilateral internal carotid artery (ICA) and/or M1/2 middle cerebral artery (MCA) occlusions were included. After being evaluated for gold-standard treatment, including endovascular thrombectomy, patients underwent early (p = 0.016), possibly reflecting subacute activation of leptomeningeal collaterals via P2-PCA. In recanalized patients, lower M1 VFR ratios at 7 ± 3 days were significantly associated with a higher NIHSS at discharge after adjusting for infarct size, age, and NIHSS at admission (p = 0.02). Total hemispheric flow significantly decreased by up to 9% between early and late measurements in both the ischaemic and non-ischaemic hemispheres (p = 0.005). Conclusions: qMRA may help to understand flow status and collateral pathway activation after LVO stroke. Past the acute phase, low arterial flow to the affected region is associated with poorer neurological status, including after successful recanalization.
- 31 January 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (2) , 171
Open AccessSerial Intracranial Flow Rate Measurements Using Quantitative Magnetic Resonance Angiography Following Large-Vessel Occlusion Stroke
Background/Objectives: Haemodynamic changes following ischaemic large-vessel occlusion (LVO) stroke might affect clinical outcome, including after endovascular recanalization. Using non-invasive quantitative MRA (qMRA), we report for the first time serial intracranial flow rate measurements following LVO and investigate flow rate changes, collateral pathway development, and their possible clinical significance. Methods: We report data from the prospective IMPreST study (Interplay of Microcirculation and Plasticity after Ischemic Stroke, registered at clinicaltrials.gov, no. NCT04035746). Patients with first-ever unilateral internal carotid artery (ICA) and/or M1/2 middle cerebral artery (MCA) occlusions were included. After being evaluated for gold-standard treatment, including endovascular thrombectomy, patients underwent early (p = 0.016), possibly reflecting subacute activation of leptomeningeal collaterals via P2-PCA. In recanalized patients, lower M1 VFR ratios at 7 ± 3 days were significantly associated with a higher NIHSS at discharge after adjusting for infarct size, age, and NIHSS at admission (p = 0.02). Total hemispheric flow significantly decreased by up to 9% between early and late measurements in both the ischaemic and non-ischaemic hemispheres (p = 0.005). Conclusions: qMRA may help to understand flow status and collateral pathway activation after LVO stroke. Past the acute phase, low arterial flow to the affected region is associated with poorer neurological status, including after successful recanalization.
- 22 January 2026
- Published by Massachusetts Medical Society in NEJM AI
- Vol. 3 (2)
Silent Validation of a Longitudinal Model for Predicting Delayed Cerebral Ischemia in Real Time after Subarachnoid Hemorrhage
- 22 January 2026
- Published by Massachusetts Medical Society in NEJM AI
- Vol. 3 (2)
Silent Validation of a Longitudinal Model for Predicting Delayed Cerebral Ischemia in Real Time after Subarachnoid Hemorrhage
- Open Access
- 1 January 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (1)
Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study
Introduction: Recent studies in stroke patients from predominantly Asian populations have underscored the significance of trimethylamine N-oxide (TMAO) as a valuable blood biomarker for predicting incident strokes and major adverse cardiovascular events (MACE). However, its prognostic role after ischemic stroke in other populations is not yet comprehensively investigated. Patients and methods: We measured plasma TMAO levels in 1726 acute ischemic stroke patients (within 24 h from symptom onset) from the multicenter BIOSIGNAL cohort. Using cox and logistic regression models adjusting for demographic and vascular risk factors, we investigated the association of TMAO with recurrent stroke, MACE within 365 days and functional outcome at 90 days after stroke. Results: TMAO levels were not associated with any risk of recurrent stroke (n = 108, unadj. HR per unit increase of log (TMAO) 1.15, 95% CI 0.88–1.51, adjust. HR 1.07, 95% CI 0.78–1.47) or MACE (n = 309, unadj. HR of log (TMAO) 1.10,95% CI 0.91–1.3, adjust. HR 0.90, 95% CI 0.74–1.09). There was an univariable positive association between higher TMAO plasma levels and unfavorable functional outcome, this association remained statistically significant in the multivariable analysis (unadj. OR of log (TMAO) 1.56, 95% CI 1.34–1.81, adjust. OR 1.28, 95% CI 1.04–1.57). Conclusion: In this large cohort of acute stroke patients from a predominantly White population, TMAO had no independent association with either recurrent stroke, or MACE or death. In univariable, and multivariable analysis, there was a significant association between TMAO and unfavorable functional outcome, which might not be clinically significant due to its low effect size. Therefore, TMAO seems not to be a clinically relevant biomarker for risk stratification after stroke.
- 1 January 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (1)
Open AccessTrimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study
Introduction: Recent studies in stroke patients from predominantly Asian populations have underscored the significance of trimethylamine N-oxide (TMAO) as a valuable blood biomarker for predicting incident strokes and major adverse cardiovascular events (MACE). However, its prognostic role after ischemic stroke in other populations is not yet comprehensively investigated. Patients and methods: We measured plasma TMAO levels in 1726 acute ischemic stroke patients (within 24 h from symptom onset) from the multicenter BIOSIGNAL cohort. Using cox and logistic regression models adjusting for demographic and vascular risk factors, we investigated the association of TMAO with recurrent stroke, MACE within 365 days and functional outcome at 90 days after stroke. Results: TMAO levels were not associated with any risk of recurrent stroke (n = 108, unadj. HR per unit increase of log (TMAO) 1.15, 95% CI 0.88–1.51, adjust. HR 1.07, 95% CI 0.78–1.47) or MACE (n = 309, unadj. HR of log (TMAO) 1.10,95% CI 0.91–1.3, adjust. HR 0.90, 95% CI 0.74–1.09). There was an univariable positive association between higher TMAO plasma levels and unfavorable functional outcome, this association remained statistically significant in the multivariable analysis (unadj. OR of log (TMAO) 1.56, 95% CI 1.34–1.81, adjust. OR 1.28, 95% CI 1.04–1.57). Conclusion: In this large cohort of acute stroke patients from a predominantly White population, TMAO had no independent association with either recurrent stroke, or MACE or death. In univariable, and multivariable analysis, there was a significant association between TMAO and unfavorable functional outcome, which might not be clinically significant due to its low effect size. Therefore, TMAO seems not to be a clinically relevant biomarker for risk stratification after stroke.
- Open Access
- 7 September 2025
- Published by Oxford University Press (OUP) in European Stroke Journal
Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study
Introduction: Recent studies in stroke patients from predominantly Asian populations have underscored the significance of trimethylamine N-oxide (TMAO) as a valuable blood biomarker for predicting incident strokes and major adverse cardiovascular events (MACE). However, its prognostic role after ischemic stroke in other populations is not yet comprehensively investigated. Patients and methods: We measured plasma TMAO levels in 1726 acute ischemic stroke patients (within 24 h from symptom onset) from the multicenter BIOSIGNAL cohort. Using cox and logistic regression models adjusting for demographic and vascular risk factors, we investigated the association of TMAO with recurrent stroke, MACE within 365 days and functional outcome at 90 days after stroke. Results: TMAO levels were not associated with any risk of recurrent stroke ( n = 108, unadj. HR per unit increase of log (TMAO) 1.15, 95% CI 0.88–1.51, adjust. HR 1.07, 95% CI 0.78–1.47) or MACE ( n = 309, unadj. HR of log (TMAO) 1.10,95% CI 0.91–1.3, adjust. HR 0.90, 95% CI 0.74–1.09). There was an univariable positive association between higher TMAO plasma levels and unfavorable functional outcome, this association remained statistically significant in the multivariable analysis (unadj. OR of log (TMAO) 1.56, 95% CI 1.34–1.81, adjust. OR 1.28, 95% CI 1.04–1.57). Conclusion: In this large cohort of acute stroke patients from a predominantly White population, TMAO had no independent association with either recurrent stroke, or MACE or death. In univariable, and multivariable analysis, there was a significant association between TMAO and unfavorable functional outcome, which might not be clinically significant due to its low effect size. Therefore, TMAO seems not to be a clinically relevant biomarker for risk stratification after stroke.
- 7 September 2025
- Published by Oxford University Press (OUP) in European Stroke Journal
Open AccessTrimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study
Introduction: Recent studies in stroke patients from predominantly Asian populations have underscored the significance of trimethylamine N-oxide (TMAO) as a valuable blood biomarker for predicting incident strokes and major adverse cardiovascular events (MACE). However, its prognostic role after ischemic stroke in other populations is not yet comprehensively investigated. Patients and methods: We measured plasma TMAO levels in 1726 acute ischemic stroke patients (within 24 h from symptom onset) from the multicenter BIOSIGNAL cohort. Using cox and logistic regression models adjusting for demographic and vascular risk factors, we investigated the association of TMAO with recurrent stroke, MACE within 365 days and functional outcome at 90 days after stroke. Results: TMAO levels were not associated with any risk of recurrent stroke ( n = 108, unadj. HR per unit increase of log (TMAO) 1.15, 95% CI 0.88–1.51, adjust. HR 1.07, 95% CI 0.78–1.47) or MACE ( n = 309, unadj. HR of log (TMAO) 1.10,95% CI 0.91–1.3, adjust. HR 0.90, 95% CI 0.74–1.09). There was an univariable positive association between higher TMAO plasma levels and unfavorable functional outcome, this association remained statistically significant in the multivariable analysis (unadj. OR of log (TMAO) 1.56, 95% CI 1.34–1.81, adjust. OR 1.28, 95% CI 1.04–1.57). Conclusion: In this large cohort of acute stroke patients from a predominantly White population, TMAO had no independent association with either recurrent stroke, or MACE or death. In univariable, and multivariable analysis, there was a significant association between TMAO and unfavorable functional outcome, which might not be clinically significant due to its low effect size. Therefore, TMAO seems not to be a clinically relevant biomarker for risk stratification after stroke.
- 1 July 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (7) , 1704-1713
Role of NT-proBNP for Atrial Fibrillation Detection After Ischemic Stroke: A Time-Dependent Relationship
BACKGROUND: Atrial fibrillation detected after stroke (AFDAS) affects secondary stroke prevention, yet identification can be challenging. Easily accessible cardiac blood biomarkers such as NT-proBNP (N-terminal pro-B-type natriuretic peptide) could guide diagnostic workup, but optimal cutoff values and the time-dependent relationship between NT-proBNP and AFDAS are unclear. We aimed (1) to externally validate earlier presented NT-proBNP cutoffs for atrial fibrillation prediction and (2) to assess the time-dependent relationship of NT-proBNP and early in-hospital AFDAS versus AFDAS after discharge. METHODS: We conducted a pooled data analysis of patients with ischemic stroke from the prospective international multicenter BIOSIGNAL (Biomarker Signature of Stroke Aetiology) cohort study (European Stroke Centers from October 2014 to October 2017) and the prospective single-center Graz stroke pathway study (Austria from May 2018 to August 2020). AFDAS was defined as ≥30-s atrial fibrillation/flutter diagnosed within 1 year post-admission and categorized in in-hospital versus after discharge. NT-proBNP was assessed ≤24 hours of symptom onset. The association between NT-proBNP and AFDAS was evaluated by a multivariable logistic regression analysis. RESULTS: AFDAS was diagnosed in 374 (16%) of 2292 patients with ischemic stroke (median age, 74 years; 42% female), 268 (72%) during hospitalization, and 106 (28%) after discharge (median duration of hospitalization, 15 days). NT-proBNP levels at admission had a good predictive capacity for in-hospital AFDAS (area under the receiver operating characteristic curve, 0.83 [95% CI, 0.81–0.86]). For patients diagnosed with AFDAS after discharge, the predictive capacity of NT-proBNP was poor (area under the receiver operating characteristic curve, 0.65 [95% CI, 0.60–0.70]), and 20% had normal NT-proBNP values <125 pg/mL at admission. The NT-proBNP cutoff of 505 pg/mL exhibited high sensitivity (82%) and specificity (71%) for in-hospital AFDAS, with a negative predictive value of 96%. CONCLUSIONS: In patients with ischemic stroke, the admission NT-proBNP cutoff of 505 pg/mL seems to be a reliable predictor for in-hospital AFDAS, while the predictive capacity of NT-proBNP for AFDAS after discharge is limited. Our results might influence the designs of future secondary stroke prevention trials.
- 1 July 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (7) , 1704-1713
Role of NT-proBNP for Atrial Fibrillation Detection After Ischemic Stroke: A Time-Dependent Relationship
BACKGROUND: Atrial fibrillation detected after stroke (AFDAS) affects secondary stroke prevention, yet identification can be challenging. Easily accessible cardiac blood biomarkers such as NT-proBNP (N-terminal pro-B-type natriuretic peptide) could guide diagnostic workup, but optimal cutoff values and the time-dependent relationship between NT-proBNP and AFDAS are unclear. We aimed (1) to externally validate earlier presented NT-proBNP cutoffs for atrial fibrillation prediction and (2) to assess the time-dependent relationship of NT-proBNP and early in-hospital AFDAS versus AFDAS after discharge. METHODS: We conducted a pooled data analysis of patients with ischemic stroke from the prospective international multicenter BIOSIGNAL (Biomarker Signature of Stroke Aetiology) cohort study (European Stroke Centers from October 2014 to October 2017) and the prospective single-center Graz stroke pathway study (Austria from May 2018 to August 2020). AFDAS was defined as ≥30-s atrial fibrillation/flutter diagnosed within 1 year post-admission and categorized in in-hospital versus after discharge. NT-proBNP was assessed ≤24 hours of symptom onset. The association between NT-proBNP and AFDAS was evaluated by a multivariable logistic regression analysis. RESULTS: AFDAS was diagnosed in 374 (16%) of 2292 patients with ischemic stroke (median age, 74 years; 42% female), 268 (72%) during hospitalization, and 106 (28%) after discharge (median duration of hospitalization, 15 days). NT-proBNP levels at admission had a good predictive capacity for in-hospital AFDAS (area under the receiver operating characteristic curve, 0.83 [95% CI, 0.81–0.86]). For patients diagnosed with AFDAS after discharge, the predictive capacity of NT-proBNP was poor (area under the receiver operating characteristic curve, 0.65 [95% CI, 0.60–0.70]), and 20% had normal NT-proBNP values <125 pg/mL at admission. The NT-proBNP cutoff of 505 pg/mL exhibited high sensitivity (82%) and specificity (71%) for in-hospital AFDAS, with a negative predictive value of 96%. CONCLUSIONS: In patients with ischemic stroke, the admission NT-proBNP cutoff of 505 pg/mL seems to be a reliable predictor for in-hospital AFDAS, while the predictive capacity of NT-proBNP for AFDAS after discharge is limited. Our results might influence the designs of future secondary stroke prevention trials.
- Open Access
- 19 February 2025
- Published by MDPI AG in Brain Sciences
- Vol. 15 (2) , 211
The Value of Non-Invasive Optimal Vessel Analysis Quantitative Magnetic Resonance Angiography for Studying Flow and Collateral Patterns in Patients with Bilateral Carotid Steno-Occlusive Disease
Background/Objectives: Bilateral steno-occlusive disease of the internal carotid artery (ICA) carries an increased stroke risk with associated high morbidity and mortality. Management of these patients is often complex. In this study, we evaluate the value of non-invasive optimal vessel analysis quantitative magnetic resonance angiography (NOVA-qMRA) for studying flow and collateral patterns in patients with bilateral carotid steno-occlusive disease. Methods: Patients with bilateral ICA-stenosis ≥ 50% who received NOVA-qMRA were included in this study. The volume flow rates (VFRs) of the A2-segment of the anterior cerebral artery (A2-ACA), M1-segment of the middle cerebral artery (M1-MCA), and P2-segment of the posterior cerebral artery (P2-PCA) were analyzed. Demographic, clinical, and treatment data were collected. Results: Twenty-two patients (mean age ± SD: 68 ± 10 years) were included. Nineteen patients (86%) were symptomatic. Thirteen patients (59%) were revascularized; among them, M1-VFR was significantly lower (p-value = 0.01) on the side selected for revascularization (88 mL/min ± 53) compared to the contralateral one (130 mL/min ± 56). P2-VFR was significantly higher (p-value = 0.04) in the treated subgroup (108 mL/min ± 41) than in the non-treated one (83 mL/min ± 34). Conclusions: The present study supports the use of NOVA-qMRA to study flow and collateral patterns in patients with bilateral steno-occlusive carotid disease, especially M1- and P2-VFR. This information may be helpful for decision-making and to tailor revascularization treatment.
- 19 February 2025
- Published by MDPI AG in Brain Sciences
- Vol. 15 (2) , 211
Open AccessThe Value of Non-Invasive Optimal Vessel Analysis Quantitative Magnetic Resonance Angiography for Studying Flow and Collateral Patterns in Patients with Bilateral Carotid Steno-Occlusive Disease
Background/Objectives: Bilateral steno-occlusive disease of the internal carotid artery (ICA) carries an increased stroke risk with associated high morbidity and mortality. Management of these patients is often complex. In this study, we evaluate the value of non-invasive optimal vessel analysis quantitative magnetic resonance angiography (NOVA-qMRA) for studying flow and collateral patterns in patients with bilateral carotid steno-occlusive disease. Methods: Patients with bilateral ICA-stenosis ≥ 50% who received NOVA-qMRA were included in this study. The volume flow rates (VFRs) of the A2-segment of the anterior cerebral artery (A2-ACA), M1-segment of the middle cerebral artery (M1-MCA), and P2-segment of the posterior cerebral artery (P2-PCA) were analyzed. Demographic, clinical, and treatment data were collected. Results: Twenty-two patients (mean age ± SD: 68 ± 10 years) were included. Nineteen patients (86%) were symptomatic. Thirteen patients (59%) were revascularized; among them, M1-VFR was significantly lower (p-value = 0.01) on the side selected for revascularization (88 mL/min ± 53) compared to the contralateral one (130 mL/min ± 56). P2-VFR was significantly higher (p-value = 0.04) in the treated subgroup (108 mL/min ± 41) than in the non-treated one (83 mL/min ± 34). Conclusions: The present study supports the use of NOVA-qMRA to study flow and collateral patterns in patients with bilateral steno-occlusive carotid disease, especially M1- and P2-VFR. This information may be helpful for decision-making and to tailor revascularization treatment.